Genevac's new SampleGenie 4 for direct concentration of large sample volumes into vials

SampleGenie 4 is the latest version of Genevac’s unique technology for direct concentration of large sample volumes into vials, designed for use in the Rocket Synergy Evaporator.

Lab chemistry

Image credit: SP Scientific

SampleGenie technology enables large sample volumes to be dried directly into vials, eliminating a number of time-consuming sample handling steps and the attendant risk of errors. The latest generation SampleGenie further enhances the exceptional capabilities of the original design. Accommodating sample volumes of up to 250ml, and featuring a new vial adapter insert to suit a range of vials from 12mm to 28mm diameter and up to 70mm tall. SampleGenie 4 has been precision engineered to reduce the risk of vial breakage.

Traditionally protocols for concentration of chromatographic fractions has involved drying multiple fractions in an evaporator, re-suspending pooled fractions into a single vial and then re-drying before storage and analysis. Even with modern centrifugal evaporators such processes typically take 2-3 days to complete. The development of SampleGenie™ technology has revolutionised this process enabling samples in Genevac Rocket Synergy, HT and EZ-2 series evaporators to be dried or concentrated, directly into a single vial eliminating the need for reformatting of samples after drying. This, and the automation offered by Genevac evaporators simplifies the protocol to a single overnight drying step before storage or analysis. Not only does SampleGenie remove time consuming manual steps - it lowers labour costs and improves data reliability.

SampleGenie technology, in conjunction with Genevac evaporators, is finding widespread use in applications including environmental analysis, metabolism and toxicology studies, food and beverage research as well as post purification protocols in chemical / life science research.

For copies of application notes and further information about SampleGenie™ please visit www.evaporatorinfo.com/info15.html or contact Genevac on +44-1473-240000 / +1-845-687-5000 / email [email protected]

Genevac, part of SP Scientific, was founded in 1990.  Today the company employs around 65 people, with manufacturing, R&D and marketing headquartered in Ipswich, UK. Genevac today offers a comprehensive portfolio of evaporators to suit almost any solvent removal application, purchasing budget or productivity requirement.

Source:

Genevac Ltd.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SP Scientific Products. (2020, May 13). Genevac's new SampleGenie 4 for direct concentration of large sample volumes into vials. News-Medical. Retrieved on November 23, 2020 from https://www.news-medical.net/news/20150127/Genevacs-new-SampleGenie-4-for-direct-concentration-of-large-sample-volumes-into-vials.aspx.

  • MLA

    SP Scientific Products. "Genevac's new SampleGenie 4 for direct concentration of large sample volumes into vials". News-Medical. 23 November 2020. <https://www.news-medical.net/news/20150127/Genevacs-new-SampleGenie-4-for-direct-concentration-of-large-sample-volumes-into-vials.aspx>.

  • Chicago

    SP Scientific Products. "Genevac's new SampleGenie 4 for direct concentration of large sample volumes into vials". News-Medical. https://www.news-medical.net/news/20150127/Genevacs-new-SampleGenie-4-for-direct-concentration-of-large-sample-volumes-into-vials.aspx. (accessed November 23, 2020).

  • Harvard

    SP Scientific Products. 2020. Genevac's new SampleGenie 4 for direct concentration of large sample volumes into vials. News-Medical, viewed 23 November 2020, https://www.news-medical.net/news/20150127/Genevacs-new-SampleGenie-4-for-direct-concentration-of-large-sample-volumes-into-vials.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
AstraZeneca invests in SP Scientific LyoConstellation system to help drive GMP production of parenteral products